Eduardo Jorgensen's guest appearances

Eduardo Jorgensen

Finding Genius Podcast

Angel Invest Boston

Aquí, amb Josep Cuní

Johns Hopkins

Ana Maiques

Whitney Johnson

Alex Mashinsky

John McAfee

Ross Ulbricht

Lyn Ulbricht

Jameson Lopp

Marco Peereboom

Henry James

Megan Ramos

Danny Flood

Abel James

Nir Eyal

Perry Marshall

OwlTail

Discover angel-scale biotech:  Learn More Eduardo Jorgensen founded Medicsen to improve the care of people with diabetes. Witnessing the struggles of patients taking insulin inspired Eduardo to leave medicine and build a device and an app to simplify the control of blood sugar by patients. Sponsored by Purdue University entrepreneurship and Peter Fasse, patent attorney at Fish &amp; Richardson Highlights:    Sal Daher Introduces Eduardo Jorgensen, Founder of Medicsen What Medicsen is all About The Suggin App and What it Does Making an Insulin Device That Does Not Require Needle Injection Discussing Product Patents Sonophoresis: Sound Based Drug Delivery Raising the Funds for the Company The Role Models Behind the Startup "Even if you're comfortable getting out of your comfort zone, doing that as a dad, it's a hard thing to do." Funding for Angel Investors Making Medicsen Profitable Deep Dive into the Suggin App How the Product Works With the App Perseverance Regardless of Low Funds and No Business Experience    Topics: Biotech, Discovering Entrepreneurship, Founding Story

Discover angel-scale biotech: <a href="https://syndicate.angelinvestboston.com/en-us/the-surge-of-opportunities-in-angel-scale-biotech" rel="nofollow" target="_blank"> Learn More</a> Eduardo Jorgensen founded Medicsen to improve the care of people with diabetes. Witnessing the struggles of patients taking insulin inspired Eduardo to leave medicine and build a device and an app to simplify the control of blood sugar by patients. Sponsored by Purdue University entrepreneurship and Peter Fasse, patent attorney at Fish &amp; Richardson Highlights: <ul> <li>Sal Daher Introduces Eduardo Jorgensen, Founder of Medicsen</li> <li>What Medicsen is all About</li> <li>The Suggin App and What it Does</li> <li>Making an Insulin Device That Does Not Require Needle Injection</li> <li>Discussing Product Patents</li> <li>Sonophoresis: Sound Based Drug Delivery</li> <li>Raising the Funds for the Company</li> <li>The Role Models Behind the Startup</li> <li>"Even if you're comfortable getting out of your comfort zone, doing that as a dad, it's a hard thing to do."</li> <li>Funding for Angel Investors</li> <li>Making Medicsen Profitable</li> <li>Deep Dive into the Suggin App</li> <li>How the Product Works With the App</li> <li>Perseverance Regardless of Low Funds and No Business Experience</li> </ul> Topics: B<a href="https://www.angelinvestboston.com/episodes-gallery?topic=biotech" rel="nofollow" target="_blank">iotech</a>, D<a href="https://www.angelinvestboston.com/episodes-gallery?topic=discovering%20entrepreneurship" rel="nofollow" target="_blank">iscovering Entrepreneurship</a>, F<a href="https://www.angelinvestboston.com/episodes-gallery?topic=founding%20story" rel="nofollow" target="_blank">ounding Story</a>

Eduardo Jorgensen, Founder - Medicsen: Insulin Minus Pain

SECCIO Pipo Serrano amb Eduardo Jorgensen (Médicsen) Administrar insulina amb pegats intel·ligents

Over 100 million people in the US are now living with diabetes or prediabetes, a disease that causes poor quality of life for most. Eduardo Jorgensen set out to address this problem by establishing MedicSen, a company that’s developing a predictive algorithm capable of alerting patients up to an hour in advance of a hypoglycemic event.  The MedicSen software receives information from wearable devices such as glucose monitors and is able to predict a patient’s future glucose levels based on certain parameters, such as food intake, activity level, and levels of insulin versus glucose in the body. By alerting the patient without any input aside from food intake documentation, this technology will provide patients with relief from the constant stress and worry that accompanies diabetes. Furthermore, it’s an interactive system, which means that patients can ask it certain questions, such as whether or not it would be safe for them to consume a soda or go for a hike. But that’s not all: currently in the works is a needle-free drug delivery device in the form of a patch.  Tune in for all the details, visit medicsen.com to learn more, and reach out to Jorgensen at eduardo@medicsen.com. 

Over 100 million people in the US are now living with diabetes or prediabetes, a disease that causes poor quality of life for most. Eduardo Jorgensen set out to address this problem by establishing MedicSen, a company that’s developing a predictive algorithm capable of alerting patients up to an hour in advance of a hypoglycemic event.  The MedicSen software receives information from wearable devices such as glucose monitors and is able to predict a patient’s future glucose levels based on certain parameters, such as food intake, activity level, and levels of insulin versus glucose in the body. By alerting the patient without any input aside from food intake documentation, this technology will provide patients with relief from the constant stress and worry that accompanies diabetes. Furthermore, it’s an interactive system, which means that patients can ask it certain questions, such as whether or not it would be safe for them to consume a soda or go for a hike. But that’s not all: currently in the works is a needle-free drug delivery device in the form of a patch.  Tune in for all the details, visit <a href="http://medicsen.com" rel="nofollow" target="_blank">medicsen.com</a> to learn more, and reach out to Jorgensen at <a href="http://eduardo@medicsen.com" rel="nofollow" target="_blank">eduardo@medicsen.com</a>.

Eduardo Jorgensen, CEO-MedicSen-Non-Invasive, Predictive Technology and a Drug Delivery System Improving the Quality of Life for Patients with Diabetes